Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
NPJ Breast Cancer|December 6, 2022
Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsiesJudith Sandbank, Guillaume Bataillon, Alona Nudelman, et al.
The American Journal of Surgical Pathology|November 19, 2025
Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic VariantsAlexis Trecourt, Clémence Scard, Françoise Descotes, et al.
Gynecologic Oncology|March 12, 2026
Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesionsClaire Saule, Enora Laas, Nina Weber, et al.
Cancers|March 6, 2021
PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for ImmunotherapyBeatriz Grandal, Manon Mangiardi-Veltin, Enora Laas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2024
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapyVioleta Romero, Martina Aida Angeles, Elena Rodríguez González, et al.
Journal of Medical Genetics|October 21, 2022
<i>APC</i> germline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?Roseline Vibert, Jessica Le Gall, Bruno Buecher, et al.
Gynecologic Oncology|November 23, 2019
Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysisCécile Le Page, Kurosh Rahimi, Manuel Rodrigues, et al.
Cancers|December 11, 2020
Impact of <i>BRCA</i> Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant ChemotherapyBeatriz Grandal, Clémence Evrevin, Enora Laas, et al.
Bulletin Du Cancer|October 8, 2023
[Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours]Sabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Journal of Pathology Informatics|January 6, 2023
Can AI predict epithelial lesion categories via automated analysis of cervical biopsies: The TissueNet challenge?Nicolas Loménie, Capucine Bertrand, Rutger H J Fick, et al.
Pageof 6